There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
MedPage Today on MSN
Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug
T he FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare ...
This week, the Food and Drug Administration approved the first-ever treatment for people living with an extremely rare ...
In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...
UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
FDA approves cancer drug belantamab mafodotin-blmf for relapsed multiple myeloma in combination with bortezomib and dexamethasone.
The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
Gov. Hobbs launched the AZRx initiative to help residents save money on prescription drugs through the free ArrayRx discount ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback